A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
NCT ID: NCT00451906
Last Updated: 2016-05-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
2252 participants
INTERVENTIONAL
2006-08-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer
NCT00404703
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
NCT01333007
A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.
NCT00776698
A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.
NCT00700180
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
NCT01351415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bevacizumab + Chemotherapy
Participants with advanced or recurrent NSCLC will be administered bevacizumab infusions at a dose of 7.5 milligram per kilogram (mg/kg) or 15 mg/kg (investigator's choice) on Day 1 and then every 3 weeks, intravenously (IV) for a maximum of 6 cycles in combination with the standard of care NSCLC first-line chemotherapy in line with the licensed national prescribing information, during the treatment period. The initial dose of bevacizumab will be administered following chemotherapy; all subsequent doses could be given before or after chemotherapy.
Platinum-based chemotherapy
As prescribed
Bevacizumab [Avastin]
15 mg/kg IV on Day 1 of each 3 week cycle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platinum-based chemotherapy
As prescribed
Bevacizumab [Avastin]
15 mg/kg IV on Day 1 of each 3 week cycle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* histologically or cytologically documented inoperable, locally advanced ( stage III), metastatic (stage IV) or recurrent NSCLC other than squamous cell (tumors of mixed histology should be categorized by the predominant cell type);
* ECOG PS status 0-2;
* life expectancy \>= 12weeks;
* adequate renal, liver and hematological function.
Exclusion Criteria
* hemoptysis (\>=1/2 teaspoon of bright red blood) in previous 3 months;
* evidence of tumor invading major blood vessels on imaging;
* evidence of CNS metastases, even if previously treated.
* major surgery (including open biopsy), significant traumatic injury within 28 days prior to enrolment, or anticipation of need for major surgery during study treatment;
* prior chemotherapy for stage IIIb/IV disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Buenos Aires, , Argentina
Chaco-resistencia, , Argentina
Córdoba, , Argentina
Córdoba, , Argentina
San Miguel de Tucumán, , Argentina
St Leonards, New South Wales, Australia
Waratah, New South Wales, Australia
Auchenflower, Queensland, Australia
Chermside, Queensland, Australia
Tugun, Queensland, Australia
Box Hill, Victoria, Australia
Geelong, Victoria, Australia
Malvern, Victoria, Australia
Wodonga, Victoria, Australia
Perth, Western Australia, Australia
Sydney, New South Wales, , Australia
Bludesch, , Austria
Bregenz, , Austria
Feldkirch, , Austria
Graz, , Austria
Innsbruck, , Austria
Knittelfeld, , Austria
Kufstein, , Austria
Linz, , Austria
Linz, , Austria
Natters, , Austria
Salzburg, , Austria
Sankt Veit an der Glan, , Austria
Vienna, , Austria
Vienna, , Austria
Vienna, , Austria
Vienna, , Austria
Vienna, , Austria
Vöcklabruck, , Austria
Wels, , Austria
Zams, , Austria
Banja Luka, , Bosnia and Herzegovina
Sarajevo, , Bosnia and Herzegovina
Fortaleza, Ceará, Brazil
Vitória, Espírito Santo, Brazil
Salvador, Bahia, Estado de Bahia, Brazil
Goiânia, Goiás, Brazil
Belo Horizonte, Minas Gerais, Brazil
Belo Horizonte, Minas Gerais, Brazil
Recife, Pernambuco, Brazil
Rio de Janeiro, Rio de Janeiro, Brazil
Rio de Janeiro, Rio de Janeiro, Brazil
Rio de Janeiro, Rio de Janeiro, Brazil
Ijuí, Rio Grande do Sul, Brazil
Porto Alegre, Rio Grande do Sul, Brazil
Porto Alegre, Rio Grande do Sul, Brazil
Porto Alegre, Rio Grande do Sul, Brazil
Porto Alegre, Rio Grande do Sul, Brazil
Campinas, São Paulo, Brazil
Campinas, São Paulo, Brazil
Jaú, São Paulo, Brazil
Ribeirão Preto, São Paulo, Brazil
Santos, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
Vancouver, British Columbia, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Beijing, , China
Beijing, , China
Beijing, , China
Guangzhou, , China
Guangzhou, , China
Hangzhou, , China
Shanghai, , China
Shanghai, , China
Bogotá, , Colombia
Cali, , Colombia
Manizales, , Colombia
Brno, , Czechia
Pilsen, , Czechia
Prague, , Czechia
Aarhus, , Denmark
Herlev, , Denmark
Hillerød, , Denmark
Næstved, , Denmark
Guayaquil, , Ecuador
Quito, , Ecuador
Cairo, , Egypt
Cairo, , Egypt
Tallinn, , Estonia
Tartu, , Estonia
Helsinki, , Finland
Paimio, , Finland
Pori, , Finland
Tampere, , Finland
Aix-en-Provence, , France
Avignon, , France
Besançon, , France
Béziers, , France
Bordeaux, , France
Brest, , France
Caen, , France
Chalon-sur-Saône, , France
Clermont-Ferrand, , France
Gap, , France
Grenoble, , France
Le Chesnay, , France
Lille, , France
Lille, , France
Lille, , France
Lyon, , France
Marseille, , France
Marseille, , France
Marseille, , France
Meaux, , France
Nancy, , France
Neuilly-sur-Seine, , France
Paris, , France
Paris, , France
Perpignan, , France
Reims, , France
Saint-Julien-en-Genevois, , France
Strasbourg, , France
Strasbourg, , France
Toulon, , France
Toulon, , France
Toulouse, , France
Toulouse, , France
Valenciennes, , France
Vandœuvre-lès-Nancy, , France
Augsburg, , Germany
Bad Berka, , Germany
Bayreuth, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Bielefeld, , Germany
Bonn, , Germany
Cologne, , Germany
Coswig, , Germany
Donaustauf, , Germany
Düsseldorf, , Germany
Ebensfeld, , Germany
Erlangen, , Germany
Essen, , Germany
Frankfurt, , Germany
Freiburg im Breisgau, , Germany
Gauting, , Germany
Gerlingen, , Germany
Göttingen, , Germany
Großhansdorf, , Germany
Halle, , Germany
Hamburg, , Germany
Hamburg, , Germany
Hanover, , Germany
Hanover, , Germany
Karlsruhe, , Germany
Kiel, , Germany
Leer, , Germany
Leipzig, , Germany
Leverkusen, , Germany
Löwenstein, , Germany
Magdeburg, , Germany
Mainz, , Germany
Minden, , Germany
München, , Germany
Neuruppin, , Germany
Nuremberg, , Germany
Oldenburg, , Germany
Rostock, , Germany
Treuenbrietzen, , Germany
Ulm, , Germany
Villingen-Schwenningen, , Germany
Wiesbaden, , Germany
Wolfsburg, , Germany
Würselen, , Germany
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Shatin, , Hong Kong
Budapest, , Hungary
Mátraháza, , Hungary
Pécs, , Hungary
Szombathely, , Hungary
Törökbálint, , Hungary
Reykjavik, , Iceland
Beersheba, , Israel
Haifa, , Israel
Jerusalem, , Israel
Jerusalem, , Israel
Kfar Saba, , Israel
Ramat Gan, , Israel
Tel Aviv, , Israel
Ẕerifin, , Israel
Avezzano, Abruzzo, Italy
Pescara, Abruzzo, Italy
Bari, Apulia, Italy
Brindisi, Apulia, Italy
San Giovanni Rotondo, Apulia, Italy
Potenza, Basilicate, Italy
Rionero in Vulture, Basilicate, Italy
Catanzaro, Calabria, Italy
Avellino, Campania, Italy
Napoli, Campania, Italy
Bologna, Emilia-Romagna, Italy
Carpi, Emilia-Romagna, Italy
Modena, Emilia-Romagna, Italy
Rimini, Emilia-Romagna, Italy
Aviano, Friuli Venezia Giulia, Italy
Udine, Friuli Venezia Giulia, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Sora, Lazio, Italy
Viterbo, Lazio, Italy
Genoa, Liguria, Italy
Genoa, Liguria, Italy
La Spezia, Liguria, Italy
Bergamo, Lombardy, Italy
Cremona, Lombardy, Italy
Milan, Lombardy, Italy
Milan, Lombardy, Italy
Pavia, Lombardy, Italy
S Fermo Della Battaglia, Lombardy, Italy
Sondrio, Lombardy, Italy
Novara, Piedmont, Italy
Cagliari, Sardinia, Italy
Sassari, Sardinia, Italy
Catania, Sicily, Italy
Catania, Sicily, Italy
Palermo, Sicily, Italy
Taormina, Sicily, Italy
Ancona, The Marches, Italy
Arezzo, Tuscany, Italy
Lido di Camaiore, Tuscany, Italy
Pisa, Tuscany, Italy
Camposampiero, Veneto, Italy
Feltre - Bl, Veneto, Italy
Negrar, Veneto, Italy
Bologna, Umbria, , Italy
Forli, Emilia-Romagna, , Italy
Riga, , Latvia
Riga, , Latvia
Beirut, , Lebanon
Kaunas, , Lithuania
Klaipėda, , Lithuania
Vilnius, , Lithuania
Chihuahua City, , Mexico
León, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Arnhem, , Netherlands
Breda, , Netherlands
Eindhoven, , Netherlands
Groningen, , Netherlands
Haarlem, , Netherlands
Helmond, , Netherlands
Hoofddorp, , Netherlands
Nieuwegein, , Netherlands
Schiedam, , Netherlands
The Hague, , Netherlands
Tiel, , Netherlands
Zwolle, , Netherlands
Bialystok, , Poland
Krakow, , Poland
Lublin, , Poland
Poznan, , Poland
Warsaw, , Poland
Warsaw, , Poland
Zabrze, , Poland
Braga, , Portugal
Coimbra, , Portugal
Lisbon, , Portugal
Lisbon, , Portugal
Lisbon, , Portugal
Porto, , Portugal
Porto, , Portugal
Santa Maria da Feira, , Portugal
Setúbal, , Portugal
Vila Nova de Gaia, , Portugal
Bucharest, , Romania
Cluj-Napoca, , Romania
Timișoara, , Romania
Balashikha, , Russia
Engel's, , Russia
Irkutsk, , Russia
Kislino, Kursk Region, , Russia
Krasnodar, , Russia
Moscow, , Russia
Moscow, , Russia
Moscow, , Russia
Samara, , Russia
Smolensk, , Russia
Stavropol, , Russia
Tver', , Russia
Tyumen, , Russia
Ulyanovsk, , Russia
Belgrade, , Serbia
Bratislava, , Slovakia
Košice, , Slovakia
Nitra, , Slovakia
Poprad, , Slovakia
Golnik, , Slovenia
Ljubljana, , Slovenia
Alicante, Alicante, Spain
Elche, Alicante, Spain
Palma de Mallorca, Balearic Islands, Spain
Barcelona, Barcelona, Spain
Barcelona, Barcelona, Spain
Barcelona, Barcelona, Spain
Manresa, Barcelona, Spain
Mataró, Barcelona, Spain
Sabadell, Barcelona, Spain
Terrassa, Barcelona, Spain
Santander, Cantabria, Spain
Girona, Girona, Spain
Huesca, Huesca, Spain
A Coruña, La Coruña, Spain
Lugo, Lugo, Spain
Alcorcón, Madrid, Spain
Madrid, Madrid, Spain
Madrid, Madrid, Spain
Madrid, Madrid, Spain
Madrid, Madrid, Spain
Madrid, Madrid, Spain
Madrid, Madrid, Spain
Murcia, Murcia, Spain
Pamplona, Navarre, Spain
Salamanca, Salamanca, Spain
San Cristóbal de La Laguna, Tenerife, Spain
Valencia, Valencia, Spain
Valencia, Valencia, Spain
Valencia, Valencia, Spain
Valencia, Valencia, Spain
Barakaldo, Vizcaya, Spain
Zaragoza, Zaragoza, Spain
Gothenburg, , Sweden
Lund, , Sweden
Malmo, , Sweden
Örebro, , Sweden
Stokholm, Solna, , Sweden
Umeå, , Sweden
Uppsala, , Sweden
Aarau, , Switzerland
Baden, , Switzerland
Genolier, , Switzerland
Locarno, , Switzerland
Taichung, , Taiwan
Tainan City, , Taiwan
Taipei, , Taiwan
Taipei, , Taiwan
Taoyuan District, , Taiwan
Ankara, , Turkey (Türkiye)
Gaziantep, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Izmir, , Turkey (Türkiye)
Sıhhiye, Ankara, , Turkey (Türkiye)
Aberdeen, , United Kingdom
Belfast, , United Kingdom
Birmingham, , United Kingdom
Cambridge, , United Kingdom
Cardiff, , United Kingdom
Manchester, , United Kingdom
Nottingham, , United Kingdom
Suffolk, , United Kingdom
Barcelona, , Venezuela
Barquisimeto, , Venezuela
Porlamar, , Venezuela
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bearz A, Passalacqua R, Alabiso O, Cinieri S, Gridelli C, Cravesana C, Crino L. First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study. Clin Drug Investig. 2012 Nov;32(11):755-60. doi: 10.1007/s40261-012-0001-9.
Crino L, Dansin E, Garrido P, Griesinger F, Laskin J, Pavlakis N, Stroiakovski D, Thatcher N, Tsai CM, Wu YL, Zhou C. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study. Lancet Oncol. 2010 Aug;11(8):733-40. doi: 10.1016/S1470-2045(10)70151-0. Epub 2010 Jul 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MO19390
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.